Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Colorectal Neoplasms

  Free Subscription

Articles published in Gut

Retrieve available abstracts of 139 articles:
HTML format

Single Articles

    July 2021
  1. ABRAHAMI D, McDonald EG, Schnitzer ME, Barkun AN, et al
    Proton pump inhibitors and risk of colorectal cancer.
    Gut. 2021 Jul 1. pii: gutjnl-2021-325096. doi: 10.1136/gutjnl-2021-325096.
    PubMed     Abstract available

    June 2021
  2. PIN-VIEITO N, Tejido-Sandoval C, de Vicente-Bielza N, Sanchez-Gomez C, et al
    Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis.
    Gut. 2021 Jun 9. pii: gutjnl-2021-324856. doi: 10.1136/gutjnl-2021-324856.
    PubMed     Abstract available

    May 2021
  3. OROUJI E, Raman AT, Singh AK, Sorokin A, et al
    Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.
    Gut. 2021 May 31. pii: gutjnl-2020-322835. doi: 10.1136/gutjnl-2020-322835.
    PubMed     Abstract available

  4. MURPHY N, Campbell PT, Gunter MJ
    Are sugar-sweetened beverages contributing to the rising occurrence of colorectal cancer in young adults?
    Gut. 2021 May 20. pii: gutjnl-2021-324614. doi: 10.1136/gutjnl-2021-324614.

  5. CURTIUS K, Kabir M, Al Bakir I, Choi CHR, et al
    Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool.
    Gut. 2021 May 14. pii: gutjnl-2020-323546. doi: 10.1136/gutjnl-2020-323546.
    PubMed     Abstract available

  6. HUR J, Otegbeye E, Joh HK, Nimptsch K, et al
    Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women.
    Gut. 2021 May 6. pii: gutjnl-2020-323450. doi: 10.1136/gutjnl-2020-323450.
    PubMed     Abstract available

    March 2021
  7. ZORZI M, Battagello J, Selby K, Capodaglio G, et al
    Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.
    Gut. 2021 Mar 31. pii: gutjnl-2020-322192. doi: 10.1136/gutjnl-2020-322192.
    PubMed     Abstract available

  8. BURR NE, Plumb A, Sood R, Rembacken B, et al
    CT colonography remains an important test for colorectal cancer.
    Gut. 2021 Mar 22. pii: gutjnl-2021-324399. doi: 10.1136/gutjnl-2021-324399.

  9. CROSS AJ, Robbins EC, Pack K, Stenson I, et al
    Colorectal cancer risk following polypectomy in a multicentre, retrospective, cohort study: an evaluation of the 2020 UK post-polypectomy surveillance guidelines.
    Gut. 2021 Mar 5. pii: gutjnl-2020-323411. doi: 10.1136/gutjnl-2020-323411.
    PubMed     Abstract available

  10. MONAHAN KJ, Lincoln A, East JE, Benton S, et al
    Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic.
    Gut. 2021;70:624-626.

    February 2021
  11. CHEN HN, Shu Y, Liao F, Liao X, et al
    Genomic evolution and diverse models of systemic metastases in colorectal cancer.
    Gut. 2021 Feb 25. pii: gutjnl-2020-323703. doi: 10.1136/gutjnl-2020-323703.
    PubMed     Abstract available

  12. HUYGHE JR, Harrison TA, Bien SA, Hampel H, et al
    Genetic architectures of proximal and distal colorectal cancer are partly distinct.
    Gut. 2021 Feb 25. pii: gutjnl-2020-321534. doi: 10.1136/gutjnl-2020-321534.
    PubMed     Abstract available

    ERBB2 in anti-EGFR-resistant colorectal cancer: cancer stem cells come into play.
    Gut. 2021 Feb 22. pii: gutjnl-2020-323924. doi: 10.1136/gutjnl-2020-323924.

    January 2021
  14. MANGIAPANE LR, Nicotra A, Turdo A, Gaggianesi M, et al
    PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
    Gut. 2021 Jan 12. pii: gutjnl-2020-323553. doi: 10.1136/gutjnl-2020-323553.
    PubMed     Abstract available

  15. GEORGESON P, Pope BJ, Rosty C, Clendenning M, et al
    Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
    Gut. 2021 Jan 7. pii: gutjnl-2019-320462. doi: 10.1136/gutjnl-2019-320462.
    PubMed     Abstract available

    December 2020
  16. LAWRENCE BJ, Alexander E, Grant H, O'Connor M, et al
    Colorectal cancer and absolute risks.
    Gut. 2020 Dec 24. pii: gutjnl-2020-323505. doi: 10.1136/gutjnl-2020-323505.

  17. DEMB J, Liu L, Murphy CC, Doubeni CA, et al
    Young-onset colorectal cancer risk among individuals with iron-deficiency anaemia and haematochezia.
    Gut. 2020 Dec 18. pii: gutjnl-2020-321849. doi: 10.1136/gutjnl-2020-321849.
    PubMed     Abstract available

  18. HONG J, Guo F, Lu SY, Shen C, et al
    F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer.
    Gut. 2020 Dec 14. pii: gutjnl-2020-322780. doi: 10.1136/gutjnl-2020-322780.
    PubMed     Abstract available

  19. YONG KK, Kyaw M, Chadwick G, Sundaram K, et al
    Increasing incidence of young-onset colorectal cancers in the UK and rising mortality in rectal cancers.
    Gut. 2020;69:2267-2268.

  20. CARREGA P, Orecchia P, Quatrini L, Tumino N, et al
    Characterisation of innate lymphoid cell subsets infiltrating colorectal carcinoma.
    Gut. 2020;69:2261-2263.

  21. YAN HHN, Siu HC, Ho SL, Yue SSK, et al
    Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
    Gut. 2020;69:2165-2179.
    PubMed     Abstract available

  22. KARSENTI D, Tharsis G, Perrot B, Cattan P, et al
    Adenoma detection by Endocuff-assisted versus standard colonoscopy in routine practice: a cluster-randomised crossover trial.
    Gut. 2020;69:2159-2164.
    PubMed     Abstract available

    November 2020
  23. SUN L, Wan A, Zhou Z, Chen D, et al
    RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer.
    Gut. 2020 Nov 20. pii: gutjnl-2020-320652. doi: 10.1136/gutjnl-2020-320652.
    PubMed     Abstract available

  24. GUO S, Chen J, Chen F, Zeng Q, et al
    Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16.
    Gut. 2020 Nov 10. pii: gutjnl-2020-321187. doi: 10.1136/gutjnl-2020-321187.
    PubMed     Abstract available

  25. GUAN A, Sun L, Liu M, Mao Y, et al
    Letter to the editor: prediction of survival in colorectal cancer using artificial intelligence.
    Gut. 2020 Nov 4. pii: gutjnl-2020-323382. doi: 10.1136/gutjnl-2020-323382.

  26. MEULEN LWT, van de Wetering AJP, Debeuf MPH, Mujagic Z, et al
    Optical diagnosis of T1 CRCs and treatment consequences in the Dutch CRC screening programme.
    Gut. 2020;69:2049-2051.

  27. SIRAJ AK, Masoodi T, Bu R, Parvathareddy SK, et al
    The study of Lynch syndrome in a special population reveals a strong founder effect and an unusual mutational mechanism in familial adenomatous polyposis.
    Gut. 2020;69:2048-2049.

  28. REES CJ, Brand A, Ngu WS, Stokes C, et al
    BowelScope: Accuracy of Detection Using Endocuff Optimisation of Mucosal Abnormalities (the B-ADENOMA Study): a multicentre, randomised controlled flexible sigmoidoscopy trial.
    Gut. 2020;69:1959-1965.
    PubMed     Abstract available

  29. WANG L, Tang L, Feng Y, Zhao S, et al
    A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+) T cells in mice.
    Gut. 2020;69:1988-1997.
    PubMed     Abstract available

    October 2020
  30. D'SOUZA N, Georgiou Delisle T, Chen M, Benton S, et al
    Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
    Gut. 2020 Oct 21. pii: gutjnl-2020-321956. doi: 10.1136/gutjnl-2020-321956.
    PubMed     Abstract available

  31. CHEN H, Zheng X, Zong X, Li Z, et al
    Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer.
    Gut. 2020 Oct 9. pii: gutjnl-2020-321661. doi: 10.1136/gutjnl-2020-321661.
    PubMed     Abstract available

    September 2020
  32. TERRADAS M, Mur P, Belhadj S, Woodward ER, et al
    TP53, a gene for colorectal cancer predisposition in the absence of Li-Fraumeni-associated phenotypes.
    Gut. 2020 Sep 30. pii: gutjnl-2020-321825. doi: 10.1136/gutjnl-2020-321825.
    PubMed     Abstract available

  33. CHAPELLE N, Martel M, Toes-Zoutendijk E, Barkun AN, et al
    Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population.
    Gut. 2020 Sep 28. pii: gutjnl-2020-320990. doi: 10.1136/gutjnl-2020-320990.
    PubMed     Abstract available

  34. PENG SM, Hsu WF, Wang YW, Lin LJ, et al
    Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
    Gut. 2020 Sep 28. pii: gutjnl-2020-320761. doi: 10.1136/gutjnl-2020-320761.
    PubMed     Abstract available

  35. BIBAULT JE, Chang DT, Xing L
    Development and validation of a model to predict survival in colorectal cancer using a gradient-boosted machine.
    Gut. 2020 Sep 4. pii: gutjnl-2020-321799. doi: 10.1136/gutjnl-2020-321799.
    PubMed     Abstract available

    August 2020
  36. LOVEDAY C, Sud A, Jones ME, Broggio J, et al
    Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Gut. 2020 Aug 27. pii: gutjnl-2020-321650. doi: 10.1136/gutjnl-2020-321650.
    PubMed     Abstract available

  37. MCGORAN JJ, Kadri SR, Moreman C, Wurm P, et al
    A polypoidal 'non-polyp' in the colon.
    Gut. 2020;69:1381-1451.

    July 2020
  38. LO PRESTI E, Corsale AM, Di Simone M, Dieli F, et al
    Characterisation of gammadelta T cells infiltrating colorectal cancer.
    Gut. 2020 Jul 31. pii: gutjnl-2020-322101. doi: 10.1136/gutjnl-2020-322101.

  39. SIRINUKUNWATTANA K, Domingo E, Richman SD, Redmond KL, et al
    Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
    Gut. 2020 Jul 20. pii: gutjnl-2019-319866. doi: 10.1136/gutjnl-2019-319866.
    PubMed     Abstract available

  40. LIANG JQ, Li T, Nakatsu G, Chen YX, et al
    A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer.
    Gut. 2020;69:1248-1257.
    PubMed     Abstract available

  41. LI J, Wang R, Zhou X, Wang W, et al
    Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.
    Gut. 2020;69:1283-1293.
    PubMed     Abstract available

  42. HEICHLER C, Scheibe K, Schmied A, Geppert CI, et al
    STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis.
    Gut. 2020;69:1269-1282.
    PubMed     Abstract available

    June 2020
  43. VLEUGELS JLA, Koens L, Dijkgraaf MGW, Houwen B, et al
    Suboptimal endoscopic cancer recognition in colorectal lesions in a national bowel screening programme.
    Gut. 2020;69:977-980.

    April 2020
  44. SHAHIDI N, Sidhu M, Vosko S, van Hattem WA, et al
    Endoscopic mucosal resection is effective for laterally spreading lesions at the anorectal junction.
    Gut. 2020;69:673-680.
    PubMed     Abstract available

    March 2020
  45. TJALMA JJJ, Koller M, Linssen MD, Hartmans E, et al
    Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer.
    Gut. 2020;69:406-410.

  46. SENORE C, Zappa M, Campari C, Crotta S, et al
    Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
    Gut. 2020;69:523-530.
    PubMed     Abstract available

    February 2020
  47. WAN QY, Zhao R, Wang Y, Wu Y, et al
    Antibiotic use and risk of colorectal cancer: a meta-analysis of 412 450 participants.
    Gut. 2020 Feb 28. pii: gutjnl-2020-320826. doi: 10.1136/gutjnl-2020-320826.

  48. YEOH YK, Chen Z, Wong MCS, Hui M, et al
    Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor.
    Gut. 2020 Feb 12. pii: gutjnl-2019-319635. doi: 10.1136/gutjnl-2019-319635.
    PubMed     Abstract available

  49. NG SC, Kyaw MH, Suen BY, Tse YK, et al
    Prospective colonoscopic study to investigate risk of colorectal neoplasms in first-degree relatives of patients with non-advanced adenomas.
    Gut. 2020;69:304-310.
    PubMed     Abstract available

    January 2020
  50. PICHLER M, Rodriguez-Aguayo C, Nam SY, Dragomir MP, et al
    Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.
    Gut. 2020 Jan 27. pii: gutjnl-2019-318903. doi: 10.1136/gutjnl-2019-318903.
    PubMed     Abstract available

  51. CROSS AJ, Robbins EC, Pack K, Stenson I, et al
    Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study.
    Gut. 2020 Jan 17. pii: gutjnl-2019-320036. doi: 10.1136/gutjnl-2019-320036.
    PubMed     Abstract available

  52. BLEIJENBERG AG, IJspeert JE, van Herwaarden YJ, Carballal S, et al
    Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.
    Gut. 2020;69:112-121.
    PubMed     Abstract available

    December 2019
  53. MA W, Chan AT
    Antibiotic use and colorectal cancer: a causal association?
    Gut. 2019 Dec 24. pii: gutjnl-2019-319792. doi: 10.1136/gutjnl-2019-319792.

  54. ZORZI M, Cavestro GM, Guzzinati S, Dal Maso L, et al
    Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults.
    Gut. 2019 Dec 16. pii: gutjnl-2019-320406. doi: 10.1136/gutjnl-2019-320406.

  55. MATHEW A, Baby B, Wang K, Sirohi B, et al
    Colorectal cancer incidence in younger adults in India.
    Gut. 2019 Dec 13. pii: gutjnl-2019-320271. doi: 10.1136/gutjnl-2019-320271.

  56. MONTAZERI Z, Li X, Nyiraneza C, Ma X, et al
    Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer.
    Gut. 2019 Dec 9. pii: gutjnl-2019-319313. doi: 10.1136/gutjnl-2019-319313.
    PubMed     Abstract available

  57. DE BARRIOS O, Sanchez-Moral L, Cortes M, Ninfali C, et al
    ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells.
    Gut. 2019;68:2129-2141.
    PubMed     Abstract available

    November 2019
  58. REICHLING C, Taieb J, Derangere V, Klopfenstein Q, et al
    Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study.
    Gut. 2019 Nov 28. pii: gutjnl-2019-319292. doi: 10.1136/gutjnl-2019-319292.
    PubMed     Abstract available

  59. MONAHAN KJ, Bradshaw N, Dolwani S, Desouza B, et al
    Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).
    Gut. 2019 Nov 28. pii: gutjnl-2019-319915. doi: 10.1136/gutjnl-2019-319915.
    PubMed     Abstract available

  60. RUTTER MD, East J, Rees CJ, Cripps N, et al
    British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.
    Gut. 2019 Nov 27. pii: gutjnl-2019-319858. doi: 10.1136/gutjnl-2019-319858.
    PubMed     Abstract available

    October 2019
  61. KUIPERS EJ, Grobbee EJ
    Personalised screening for colorectal cancer, ready for take-off.
    Gut. 2019 Oct 15. pii: gutjnl-2019-319677. doi: 10.1136/gutjnl-2019-319677.

  62. WANG P, Berzin TM, Glissen Brown JR, Bharadwaj S, et al
    Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study.
    Gut. 2019;68:1813-1819.
    PubMed     Abstract available

    September 2019
  63. KLEEMAN SO, Koelzer VH, Jones HJ, Vazquez EG, et al
    Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification.
    Gut. 2019 Sep 28. pii: gutjnl-2019-319126. doi: 10.1136/gutjnl-2019-319126.
    PubMed     Abstract available

  64. SIEGEL RL, Torre LA, Soerjomataram I, Hayes RB, et al
    Global patterns and trends in colorectal cancer incidence in young adults.
    Gut. 2019 Sep 5. pii: gutjnl-2019-319511. doi: 10.1136/gutjnl-2019-319511.
    PubMed     Abstract available

  65. SCOTT AJ, Alexander JL, Merrifield CA, Cunningham D, et al
    International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis.
    Gut. 2019;68:1624-1632.
    PubMed     Abstract available

  66. KANDEL P, Brand EC, Pelt J, Ball CT, et al
    Endoscopic scar assessment after colorectal endoscopic mucosal resection scars: when is biopsy necessary (EMR Scar Assessment Project for Endoscope (ESCAPE) trial).
    Gut. 2019;68:1633-1641.
    PubMed     Abstract available

  67. CROSS AJ, Wooldrage K, Robbins EC, Kralj-Hans I, et al
    Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.
    Gut. 2019;68:1642-1652.
    PubMed     Abstract available

    August 2019
  68. ZHANG J, Haines C, Watson AJM, Hart AR, et al
    Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study.
    Gut. 2019 Aug 19. pii: gutjnl-2019-318593. doi: 10.1136/gutjnl-2019-318593.
    PubMed     Abstract available

    July 2019
  69. WEI T, Luo P, Zhang X, Zhu W, et al
    Comparison of the incidence of colorectal cancer in young adults between the USA and Europe.
    Gut. 2019 Jul 31. pii: gutjnl-2019-319391. doi: 10.1136/gutjnl-2019-319391.

  70. REN J, Yao M
    Cautious view on the link between yoghurt consumption and risk of colorectal cancer.
    Gut. 2019 Jul 29. pii: gutjnl-2019-319430. doi: 10.1136/gutjnl-2019-319430.

  71. DE VRIES NL, van Unen V, Ijsselsteijn ME, Abdelaal T, et al
    High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity.
    Gut. 2019 Jul 3. pii: gutjnl-2019-318672. doi: 10.1136/gutjnl-2019-318672.
    PubMed     Abstract available

    June 2019
  72. ZHENG X, Wu K, Song M, Ogino S, et al
    Yogurt consumption and risk of conventional and serrated precursors of colorectal cancer.
    Gut. 2019 Jun 17. pii: gutjnl-2019-318374. doi: 10.1136/gutjnl-2019-318374.

  73. BAHIN FF, Heitman SJ, Bourke MJ
    Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
    Gut. 2019;68:1130.

    May 2019
  74. DOHAN A, Gallix B, Guiu B, Le Malicot K, et al
    Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
    Gut. 2019 May 17. pii: gutjnl-2018-316407. doi: 10.1136/gutjnl-2018-316407.
    PubMed     Abstract available

  75. VUIK FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, et al
    Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.
    Gut. 2019 May 16. pii: gutjnl-2018-317592. doi: 10.1136/gutjnl-2018-317592.
    PubMed     Abstract available

    April 2019
  76. ZORZI M, Zappa M
    Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
    Gut. 2019 Apr 30. pii: gutjnl-2019-318589. doi: 10.1136/gutjnl-2019-318589.
    PubMed     Abstract available

  77. VAUGHAN-SHAW PG, Zgaga L, Ooi LY, Theodoratou E, et al
    Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response.
    Gut. 2019 Apr 25. pii: gutjnl-2018-317922. doi: 10.1136/gutjnl-2018-317922.
    PubMed     Abstract available

  78. LANNAGAN TRM, Lee YK, Wang T, Roper J, et al
    Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.
    Gut. 2019;68:684-692.
    PubMed     Abstract available

  79. TIE J, Cohen JD, Wang Y, Li L, et al
    Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.
    Gut. 2019;68:663-671.
    PubMed     Abstract available

    February 2019
  80. CHEUNG KS, Chen L, Chan EW, Seto WK, et al
    Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients.
    Gut. 2019 Feb 26. pii: gutjnl-2018-317714. doi: 10.1136/gutjnl-2018-317714.
    PubMed     Abstract available

  81. HE Z, Gharaibeh RZ, Newsome RC, Pope JL, et al
    Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin.
    Gut. 2019;68:289-300.
    PubMed     Abstract available

  82. NGU WS, Bevan R, Tsiamoulos ZP, Bassett P, et al
    Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trial.
    Gut. 2019;68:280-288.
    PubMed     Abstract available

    January 2019
  83. LOPEZ A, Bouvier AM, Jooste V, Cottet V, et al
    Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population.
    Gut. 2019;68:111-117.
    PubMed     Abstract available

    December 2018
  84. STJARNGRIM J, Ekbom A, Hammar U, Hultcrantz R, et al
    Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Gut. 2018 Dec 15. pii: gutjnl-2018-316651. doi: 10.1136/gutjnl-2018-316651.
    PubMed     Abstract available

  85. SENORE C, Basu P, Anttila A, Ponti A, et al
    Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report.
    Gut. 2018 Dec 10. pii: gutjnl-2018-317293. doi: 10.1136/gutjnl-2018-317293.
    PubMed     Abstract available

    Occult blood in faeces: a window into health beyond the colorectum?
    Gut. 2018;67:2079-2080.

    November 2018
  87. COKER OO, Nakatsu G, Dai RZ, Wu WKK, et al
    Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
    Gut. 2018 Nov 24. pii: gutjnl-2018-317178. doi: 10.1136/gutjnl-2018-317178.
    PubMed     Abstract available

  88. BAHIN FF, Heitman SJ, Rasouli KN, Mahajan H, et al
    Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
    Gut. 2018;67:1965-1973.
    PubMed     Abstract available

  89. BUGAJSKI M, Wieszczy P, Hoff G, Rupinski M, et al
    Modifiable factors associated with patient-reported pain during and after screening colonoscopy.
    Gut. 2018;67:1958-1964.
    PubMed     Abstract available

    October 2018
  90. CHEN H, Li N, Ren J, Feng X, et al
    Participation and yield of a population-based colorectal cancer screening programme in China.
    Gut. 2018 Oct 30. pii: gutjnl-2018-317124. doi: 10.1136/gutjnl-2018-317124.
    PubMed     Abstract available

  91. DEKKER E, IJspeert JEG
    Serrated pathway: a paradigm shift in CRC prevention.
    Gut. 2018;67:1751-1752.

  92. GERNER RR, Klepsch V, Macheiner S, Arnhard K, et al
    NAD metabolism fuels human and mouse intestinal inflammation.
    Gut. 2018;67:1813-1823.
    PubMed     Abstract available

    September 2018
  93. GUDRA D, Shoaie S, Fridmanis D, Klovins J, et al
    A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies.
    Gut. 2018 Sep 21. pii: gutjnl-2018-316225. doi: 10.1136/gutjnl-2018-316225.

  94. TOES-ZOUTENDIJK E, Kooyker AI, Elferink MA, Spaander MCW, et al
    Stage distribution of screen-detected colorectal cancers in the Netherlands.
    Gut. 2018;67:1745-1746.

  95. TOYOSHIMA O, Hata K, Yoshida S, Arita M, et al
    New-generation chromoendoscopy may increase confidence in the DISCARD2 study.
    Gut. 2018;67:1742-1743.

  96. MURPHY G, Cross AJ, Dawsey SM, Stanczyk FZ, et al
    Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study.
    Gut. 2018;67:1646-1651.
    PubMed     Abstract available

    August 2018
  97. POHL H, Kaminski MF
    Mindful choice of endoscopic resection for large colorectal lesions.
    Gut. 2018;67:1374-1375.

  98. FUCCIO L, Repici A, Hassan C, Ponchon T, et al
    Why attempt en bloc resection of non-pedunculated colorectal adenomas? A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection.
    Gut. 2018;67:1464-1474.
    PubMed     Abstract available

    July 2018
  99. LIBBY G, Fraser CG, Carey FA, Brewster DH, et al
    Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality.
    Gut. 2018 Jul 16. pii: gutjnl-2018-316483. doi: 10.1136/gutjnl-2018-316483.
    PubMed     Abstract available

  100. BAKER AM, Cross W, Curtius K, Al Bakir I, et al
    Evolutionary history of human colitis-associated colorectal cancer.
    Gut. 2018 Jul 10. pii: gutjnl-2018-316191. doi: 10.1136/gutjnl-2018-316191.
    PubMed     Abstract available

  101. CHANG WL, Jackson C, Riel S, Cooper HS, et al
    Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.
    Gut. 2018;67:1290-1298.
    PubMed     Abstract available

    June 2018
  102. KOMIYA Y, Shimomura Y, Higurashi T, Sugi Y, et al
    Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity.
    Gut. 2018 Jun 22. pii: gutjnl-2018-316661. doi: 10.1136/gutjnl-2018-316661.

  103. WIETEN E, Schreuders EH, Grobbee EJ, Nieboer D, et al
    Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 22. pii: gutjnl-2017-315340. doi: 10.1136/gutjnl-2017-315340.
    PubMed     Abstract available

  104. NIEUWENBURG SAV, Vuik FER, Kruip MJHA, Kuipers EJ, et al
    Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 5. pii: gutjnl-2018-316344. doi: 10.1136/gutjnl-2018-316344.
    PubMed     Abstract available

    May 2018
  105. GLUCK N, Half EE, Bieber V, Schwartz D, et al
    Novel prep-less X-ray imaging capsule for colon cancer screening: a feasibility study.
    Gut. 2018 May 21. pii: gutjnl-2018-316127. doi: 10.1136/gutjnl-2018-316127.

  106. TEN HOVE JR, Shah SC, Shaffer SR, Bernstein CN, et al
    Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study.
    Gut. 2018 May 2. pii: gutjnl-2017-315440. doi: 10.1136/gutjnl-2017-315440.
    PubMed     Abstract available

  107. BARENDSE RM, Musters GD, de Graaf EJR, van den Broek FJC, et al
    Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study).
    Gut. 2018;67:837-846.
    PubMed     Abstract available

    April 2018
  108. KONG F, Li L, Wang G, Deng X, et al
    VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells.
    Gut. 2018 Apr 25. pii: gutjnl-2018-316627. doi: 10.1136/gutjnl-2018-316627.

  109. SMITH T, Muller DC, Moons KGM, Cross AJ, et al
    Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
    Gut. 2018 Apr 3. pii: gutjnl-2017-315730. doi: 10.1136/gutjnl-2017-315730.
    PubMed     Abstract available

  110. CAO Y, Wu K, Mehta R, Drew DA, et al
    Long-term use of antibiotics and risk of colorectal adenoma.
    Gut. 2018;67:672-678.
    PubMed     Abstract available

  111. MOUSSATA D, Allez M, Cazals-Hatem D, Treton X, et al
    Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Gut. 2018;67:616-624.
    PubMed     Abstract available

  112. BATTERSBY NJ, Bouliotis G, Emmertsen KJ, Juul T, et al
    Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score.
    Gut. 2018;67:688-696.
    PubMed     Abstract available

    March 2018
  113. JOO JE, Jayasekara H, Wong EM, Clendenning M, et al
    Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316122. doi: 10.1136/gutjnl-2018-316122.

  114. OKUGAWA Y, Toiyama Y, Kusunoki M, Goel A, et al
    Re: Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study.
    Gut. 2018 Mar 13. pii: gutjnl-2018-316205. doi: 10.1136/gutjnl-2018-316205.

  115. RIGTER LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, et al
    Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Gut. 2018;67:447-455.
    PubMed     Abstract available

  116. DAVENPORT JR, Su T, Zhao Z, Coleman HG, et al
    Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.
    Gut. 2018;67:456-465.
    PubMed     Abstract available

    February 2018
  117. SUNDKVIST A, Myte R, Palmqvist R, Harlid S, et al
    Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer.
    Gut. 2018 Feb 28. pii: gutjnl-2018-316110. doi: 10.1136/gutjnl-2018-316110.

  118. CREMONESI E, Governa V, Garzon JFG, Mele V, et al
    Gut microbiota modulate T cell trafficking into human colorectal cancer.
    Gut. 2018 Feb 6. pii: gutjnl-2016-313498. doi: 10.1136/gutjnl-2016-313498.
    PubMed     Abstract available

  119. OVERWATER A, Kessels K, Elias SG, Backes Y, et al
    Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes.
    Gut. 2018;67:284-290.
    PubMed     Abstract available

  120. RICHARDS CH, Ventham NT, Mansouri D, Wilson M, et al
    An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS).
    Gut. 2018;67:299-306.
    PubMed     Abstract available

    January 2018
  121. WILLIAMS DS, Mouradov D, Jorissen RN, Newman MR, et al
    Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315664. doi: 10.1136/gutjnl-2017-315664.
    PubMed     Abstract available

  122. DE ARCANGELIS A, Chamaillard M, Simon-Assmann P, Labouesse M, et al
    Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: "Integrin a6 variants and colorectal cancer" by Beaulieu JF.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315727. doi: 10.1136/gutjnl-2017-315727.

  123. BACKES Y, Schwartz MP, Ter Borg F, Wolfhagen FHJ, et al
    Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study).
    Gut. 2018 Jan 3. pii: gutjnl-2017-314723. doi: 10.1136/gutjnl-2017-314723.
    PubMed     Abstract available

  124. LAWLER M, Alsina D, Adams RA, Anderson AS, et al
    Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
    Gut. 2018;67:179-193.
    PubMed     Abstract available

  125. CARBALLAL S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, et al
    Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Gut. 2018;67:70-78.
    PubMed     Abstract available

    December 2017
  126. DEMING DA
    Tailoring the colorectal cancer disease assessment to the treatment strategy.
    Gut. 2017 Dec 21. pii: gutjnl-2017-315394. doi: 10.1136/gutjnl-2017-315394.

  127. SIEVERS CK, Zou LS, Pickhardt PJ, Matkowskyj KA, et al
    Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.
    Gut. 2017;66:2132-2140.
    PubMed     Abstract available

    November 2017
  128. CHOI CR, Al Bakir I, Ding NJ, Lee GH, et al
    Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study.
    Gut. 2017 Nov 17. pii: gutjnl-2017-314190. doi: 10.1136/gutjnl-2017-314190.
    PubMed     Abstract available

  129. WAN L, Yu W, Shen E, Sun W, et al
    SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Gut. 2017 Nov 7. pii: gutjnl-2017-314983. doi: 10.1136/gutjnl-2017-314983.
    PubMed     Abstract available

  130. GUNDERT M, Edelmann D, Benner A, Jansen L, et al
    Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gut. 2017 Nov 3. pii: gutjnl-2017-314711. doi: 10.1136/gutjnl-2017-314711.
    PubMed     Abstract available

  131. ZORZI M, Hassan C, Capodaglio G, Fedato C, et al
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test.
    Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753.
    PubMed     Abstract available

    October 2017
  132. MAZARD T, Boonsirikamchai P, Overman MJ, Asran MA, et al
    Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
    Gut. 2017 Oct 30. pii: gutjnl-2017-313786. doi: 10.1136/gutjnl-2017-313786.
    PubMed     Abstract available

    Integrin alpha6 variants and colorectal cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315415. doi: 10.1136/gutjnl-2017-315415.

  134. SCHRAMM C, Janhsen K, Demir M, Nierhoff D, et al
    Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices.
    Gut. 2017 Oct 21. pii: gutjnl-2017-315321. doi: 10.1136/gutjnl-2017-315321.

  135. FLEMER B, Warren RD, Barrett MP, Cisek K, et al
    The oral microbiota in colorectal cancer is distinctive and predictive.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314814. doi: 10.1136/gutjnl-2017-314814.
    PubMed     Abstract available

  136. BARAULT L, Amatu A, Siravegna G, Ponzetti A, et al
    Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Gut. 2017 Oct 5. pii: gutjnl-2016-313372. doi: 10.1136/gutjnl-2016-313372.
    PubMed     Abstract available

    August 2017
    Train-the-trainer education and colonoscopy quality indicators: where to now?
    Gut. 2017;66:1533-1534.

    June 2017
  138. BUCHANAN DD, Clendenning M, Zhuoer L, Stewart JR, et al
    Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.
    Gut. 2017;66:1170-1172.

    March 2016
  139. ADAMI HO, Bretthauer M, Emilsson L, Hernan MA, et al
    The continuing uncertainty about cancer risk in inflammatory bowel disease.
    Gut. 2016 Mar 23. pii: gutjnl-2015-311003. doi: 10.1136/gutjnl-2015-311003.

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.